4//SEC Filing
Lang Peter Frederick 4
Accession 0001209191-22-020653
CIK 0001337553other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 8:21 PM ET
Size
7.7 KB
Accession
0001209191-22-020653
Insider Transaction Report
Form 4
Lang Peter Frederick
Chief Financial Officer
Transactions
- Award
Common Stock
2022-03-18+46,297→ 46,297 total - Award
Stock Option (right to buy)
2022-03-18+160,551→ 160,551 totalExercise: $8.80Exp: 2032-03-18→ Common Stock (160,551 underlying)
Footnotes (2)
- [F1]These shares of Common Stock were granted under the Aerie Pharmaceuticals, Inc. Amended and Restated Inducement Award Plan (the "Plan") and are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of March 18, 2022.
- [F2]This Option was granted under the Plan and is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, as to 25% of the underlying shares on March 18, 2023 and as to the remaining underlying shares in substantially equal installments on each of the subsequent 36 monthly anniversaries of March 18, 2023.
Documents
Issuer
AERIE PHARMACEUTICALS INC
CIK 0001337553
Entity typeother
Related Parties
1- filerCIK 0001918982
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 8:21 PM ET
- Size
- 7.7 KB